Biotech Startups
10,099 companies tagged Biotech, with their investors and founders.
0 investors
Sethera Therapeutics develops peptide-based therapeutics using innovative enzyme chemistry research. The company focuses on commercializing novel peptide drugs derived from breakthrough scientific discoveries.
0 investors
Seurat Therapeutics is a biopharmaceutical company focused on discovering and developing novel neurotherapeutics, with research centered on immune signaling in brain health. Its work addresses conditions such as migraine and other neurological diseases.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Shuttle Pharmaceuticals operates Molecule.ai, an AI-driven software platform for molecular discovery and early-stage drug development. The platform helps researchers explore chemical space and evaluate molecular candidates to support decision-making in the earliest stages of drug development.
0 investors
0 investors
Westlake Village dermatology company developing late-stage topical and photoparticle skin treatments; assets sold to Sebacia in 2020.
0 investors
0 investors
0 investors
SignPath Pharma develops small-molecule therapeutics to prevent cardiotoxicity caused by cancer treatments and other primary therapies. The company focuses on cardio-oncology, designing molecules to protect cardiac function in patients undergoing cancer therapy.
0 investors
0 investors
0 investors
Silo Pharma is a developmental-stage biopharmaceutical company (Nasdaq: SILO) developing novel formulations of traditional and psychedelic therapeutics for underserved conditions such as stress-induced psychiatric disorders, chronic pain, and central nervous system diseases. Its pipeline includes programs for PTSD, fibromyalgia, Alzheimer's, and multiple sclerosis, pursued via the FDA 505(b)(2) pathway in collaboration with academic research partners.
0 investors
Silver Creek develops growth factor-based therapeutics to promote cell survival and growth in response to injury. The company focuses on rescuing damaged cells through targeted biologic interventions.
0 investors
0 investors
0 investors